Drug use among fathers around time of conception: Two register based surveys from Denmark and The Netherlands

Pharmacoepidemiology and Drug Safety

Volumn 13, Issue 9, 2004, Pages 609-613

  Schirm, Eric ^a,b,c   Pedersen, Lars ^b,c   Tobi, Hilde ^a   Nielsen, Gunnar L ^b,c   Sørensen, Henrik T ^b,c   de Jong van den Berg, Lolkje T W ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Drug utilisation study; Paternal exposure; Pharmacy data

Indexed keywords

ANALGESIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIDIARRHEAL AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; ANTIPROTOZOAL AGENT; ANTIRHEUMATIC AGENT; ANTITUSSIVE AGENT; ANTIULCER AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CENTRAL STIMULANT AGENT; CIMETIDINE; CORTICOSTEROID; DIAZEPAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GASTROINTESTINAL AGENT; HYPNOTIC AGENT; LAXATIVE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PSYCHOSTIMULANT AGENT; SEDATIVE AGENT; UNINDEXED DRUG; VACCINE;

ARTICLE; CONCEPTION; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DENMARK; DRUG EXPOSURE; DRUG INFORMATION; DRUG SAFETY; DRUG UTILIZATION; FATHER; HEALTH SURVEY; HUMAN; MALE; NETHERLANDS; PHARMACOEPIDEMIOLOGY; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; PURCHASING; REGISTER; REIMBURSEMENT; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; CHILD, PRESCHOOL; COMMUNITY PHARMACY SERVICES; DATABASES, FACTUAL; DENMARK; FATHERS; HUMANS; INFANT; MALE; NETHERLANDS; PHARMACEUTICAL PREPARATIONS; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES;

EID: 4644237860     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.959     Document Type: Article

References (20)

1. Trasler JM, Doerksen T. Teratogen update: paternal exposures - reproductive risks. Teratology 1999; 60: 161-172.
2. Trasler JM, Hales BF, Robaire B. Paternal cyclophosphamide treatment of rats causes fetal loss and malformations without affecting male fertility. Nature 1985; 316: 144.
3. Trasler JM, Hales BF, Robaire B. Chronic low dose cylophosphamide treatment of adult male rats: effect on fertility, pregnancy outcome and progeny. Biol Reprod 1986; 34: 275-283.
4. Wyrobek AJ. Methods and concepts in detecting abnormal reproductive outcomes of paternal origin. Reprod Toxicol 1993; 7: 3-16.
5. Olshan FA, Faustman EM. Male-mediated developmental toxicity. Annu Rev Pub Health 1993; 14: 159-181.
6. Savitz DA, Sonnefeld NL, Olshan AF. Review of epidemiologic studies of paternal occupational exposure and spontaneous abortion. Am J Ind Med 1994; 25: 361-383.
7. Robbins WA, Meistrich ML, Moore D, et al. Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm. Nat Genet 1997; 16: 74-78.
8. Byrne J, Mulvihill JJ, Myers MH, et al. Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer. N Engl J Med 1987; 317: 1315-1321.
9. Byrne J, Rasmussen SA, Steinhorn SC, et al. Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet 1998; 62: 45-52.
10. Rajapakse RO, Korelitz BI, Zlatanic J, Baiocco PJ, Gleim GW. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol 2000; 95: 684-688.
11. Moody GA, Probert C, Jayanthi V, Mayberry JF. The effects of chronic ill health and treatment with sulfphasalazine on fertility amongst men and women with inflammatory bowel disease in Leicestershire. Int J Colorect 1997; 12: 220-224.
12. Monster TBM, Janssen WMT, De Jong PE, De Jong-van den Berg LTW. Pharmacy data in epidemiological studies: an easy to obtain and reliable tool. Pharmacoepidemiol Drug Safe 2002; 11: 379-384.
13. Tobi H, Van den Berg PB, De Jong-van den Berg LTW. The InterAction database: synergy of science and practice in pharmacy. In Medical Data Analysis: Lecture Notes in Computer Sciences (1933), Brause RW, Hanisch E (eds). Springer: Frankfurt, 2000; 206-211.
14. Schirm E, Tobi H, de Jong-van den Berg LTW. Identifying parents in pharmacy data: a tool for the continuous monitoring of drug exposure to unborn children. J Clin Epidemiol (In press).
15. WHO Collaborating Centre for Drug Statistic Methodology. Guidelines for ATC Classification and DDD Assignment. WHO: Oslo, 1999.
16. Van Thiel DH, Gavaler JS, Smith WI, Jr, Paul G. Hypothalamic-pituitary-gonadal dysfunction in men using cimetidine. N Engl J Med 1979; 300: 1012-1015.
17. Bishop JB. Witt KL, Sloane RA. Genetic toxicities of human teratogens. Mutat Res 1997; 396: 9-43.
18. Nelson BK, Moorman WJ, Schrader SM. Review of experimental male-mediated behavioural and neurochemical disorders. Neurotoxicol Teratol 1996; 18: 611-616.
19. Joffe JM, Soyka LF. Paternal drug exposure: effects on reproduction and progeny. Semin Perinal 1982; 6: 116-124.
20. Caminos-Torres R, Ma L, Snyder PJ. Gynecomastia and semen abnormalities induced by spironolocatone in normal men. J Clin Endocrin Metab 1977; 45: 255-260.